Enzyme immunoassay using baculovirus-expressed human calicivirus (Mexico) for the measurement of IgG responses and determining its seroprevalence in London, UK.
The use of an enzyme immunoassay (EIA) employing a baculovirus-expressed recombinant human calicivirus (Mexico virus, MxV) for the detection of IgG-specific antibodies is described. MxV appeared to be related antigenically to a strain of small round structured virus, SRSV/UK4/Leeds/91, which had previously been shown by solid phase immune electron microscopy (SPIEM) to be related to Snow Mountain agent (SMA). One other outbreak which occurred in San Anita, USA in 1980 and was due to consumption of contaminated water was caused by a virus antigenically related to MxV. Volunteers and patients who developed significant IgG responses to rMxV showed anamnestic IgG responses (2 to 4-fold) in the recombinant Norwalk virus (rNV) IgG assay. Patients and volunteers who were known to have been infected with several other strains of calicivirus/small round spherical viruses (SRSV) including NV and SRSV UK3 showed no significant antibody response to rMxV in the EIA. A seroepidemiological survey of sera from 338 children in London showed that infection with MxV occurred earlier in life than NV. Primary infections with MxV were common after the age of 6 months. Over 70% of children had evidence of infection by the ages of 2 years, whereas only 12% of these children had been infected with NV. High concentrations of maternal antibody were present during the first month of life which was detected in 96% of the neonates. The results suggest that the high sensitivity of the EIA may be detecting maternal antibody throughout the first 8 months of life.
Parker
S P
SP
Department of Virology, Institute of Child Health, London, United Kingdom.
Cubitt
W D
WD
Jiang
X
X
D000293:Adolescent; D000328:Adult; D000914:Antibodies, Viral / Q000097:blood*; D016367:Baculoviridae; D002139:Caliciviridae / Q000235:genetics / Q000276:immunology*; D017250:Caliciviridae Infections / Q000453:epidemiology* / Q000276:immunology / Q000821:virology; D002648:Child; D002675:Child, Preschool; D006801:Humans; D007124:Immunoenzyme Techniques; D007074:Immunoglobulin G / Q000097:blood*; D007223:Infant; D007231:Infant, Newborn; D009663:Norwalk virus / Q000276:immunology; D015995:Prevalence; D011993:Recombinant Fusion Proteins; D012680:Sensitivity and Specificity; D016036:Seroepidemiologic Studies; D006113:United Kingdom / Q000453:epidemiology; D014764:Viral Proteins / Q000276:immunology
D000914:Antibodies, Viral; D007074:Immunoglobulin G; D011993:Recombinant Fusion Proteins; D014764:Viral Proteins